Use of the NMDA antagonist magnesium sulfate during monitored anesthesia care for shockwave lithotripsy
Journal of Endourology, cilt.21, sa.2, ss.145-150, 2007 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 21 Sayı: 2
- Basım Tarihi: 2007
- Doi Numarası: 10.1089/end.2006.0195
- Dergi Adı: Journal of Endourology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.145-150
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Purpose: To assess whether intravenous magnesium sulfate infusion affects analgesic requirements during monitored anesthesia care (MAC) for shockwave lithotripsy (SWL). Patients and Methods: Fifty patients in ASA class I or II undergoing SWL with MAC were randomized into two groups. Induction of MAC was produced by bolus doses of midazolam 0.03 mg/kg-1 and fentanyl 0.5 μg/kg-1 followed by intravenous infusion of midazolam 0.015 to 0.06 mg/kg-1/hr-1 with fentanyl supplementation 0.2 μg/kg-1. In addition, group I patients received magnesium sulfate 30 mg/kg-1 intravenously as a bolus dose followed by a continuous infusion of 10 mg/kg-1/hr-1 beginning 15 minutes before induction of sedation. The midazolam infusion rate and additional fentanyl doses were adjusted by verbal analog scale (VAS) measurements, observer assessment sedation score (OAA/S), and achieving a target bispectral index (BIS) in a range of 70 to 90. At the end of SWL, the total midazolam and total fentanyl consumptions were recorded, and the serum magnesium concentration was measured. Results: Magnesium caused significant decreases in the total consumption of midazolam (P = 0.001) and fentanyl (P = 0.001). The VAS values at the 15th, 20th, and 25th minute in group I were significantly lower than in group II. In group I, hemodynamic and arterial oxygen parameters were better than in group II. Conclusion: A magnesium bolus and infusion can be utilized to reduce analgesic requirements under MAC during SWL. © Mary Ann Liebert, Inc.